Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02770586 · ClinicalTrials.gov registry record · NA
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02770586: Completed NA study, sponsored by Mayo Clinic.
NCT02770586 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02770586, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The hypothesis of this study is that positron emission mammography will provide comparable sensitivity to contrast-enhanced breast MRI in women with a high suspicion of breast cancer. The aim of this study is to determine the sensitivity of Positron Emission Mammography (PEM) relative to that of Contrast-enhanced breast MRI (CE-MRI) in women with a high suspicion of breast cancer
Interventions
- DIAGNOSTIC_TEST Breast PET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-10-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02770586
The ClinicalTrials.gov registry entry for NCT02770586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breast PET is the first listed.
NCT02770586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02770586 about?
NCT02770586 is a clinical study titled "Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI". The hypothesis of this study is that positron emission mammography will provide comparable sensitivity to contrast-enhanced breast MRI in women with a high suspicion of breast cancer. The aim of this study is to determine the sensitivity of Positron Emission Mammography (PEM) relative to that of Co...
What is the current status of trial NCT02770586?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-08. Estimated completion is 2019-10-12.
What interventions are being tested in trial NCT02770586?
The interventions under investigation include: Breast PET (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02770586?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.